BIOMAT Database Logo BIOMAT Database Logo

In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction. 2013

O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Department of Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.

The involvement of toll-like receptor 9 (TLR9), a receptor for bacterial DNA, in septic cardiac depression has not been clarified in vivo. Thus, the aim of the study was to test possible TLR9 inhibitors (H154-thioate, IRS954-thioate, and chloroquine) for their ability to protect the cardiovascular system in a murine model of CpG oligodeoxynucleotide- (ODN-) dependent systemic inflammation. Sepsis was induced by i.p. application of the TLR9 agonist 1668-thioate in C57BL/6 wild type (WT) and TLR9-deficient (TLR9-D) mice. Thirty minutes after stimulation TLR9 antagonists were applied i.v. Survival was monitored up to 18 h after stimulation. Cardiac mRNA expression of inflammatory mediators was analyzed 2 h and 6 h after stimulation with 1668-thioate and hemodynamic parameters were monitored at the later time point. Stimulation with 1668-thioate induced a severe sepsis-like state with significant drop of body temperature and significantly increased mortality in WT animals. Additionally, there was a time-dependent increase of inflammatory mediators in the heart accompanied by development of septic heart failure. These effects were not observed in TLR9-D mice. Inhibition of TLR9 by the suppressive ODN H154-thioate significantly ameliorated cardiac inflammation, preserved cardiac function, and improved survival. This suppressive ODN was the most efficient inhibitor of the tested substances.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling.
January 2013, Biochimica et biophysica acta,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Inhibition of CYP2E1 attenuates chronic alcohol intake-induced myocardial contractile dysfunction and apoptosis.
January 2013, Biochimica et biophysica acta,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Losartan treatment attenuates tumor-induced myocardial dysfunction.
August 2015, Journal of molecular and cellular cardiology,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides.
February 2016, International journal of molecular sciences,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Dietary magnesium supplementation attenuates ethanol-induced myocardial dysfunction.
December 1998, Alcoholism, clinical and experimental research,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
January 2016, The Journal of surgical research,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning.
February 2004, The Annals of thoracic surgery,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling.
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Bacterial CpG-DNA licenses TLR9.
January 2002, Current topics in microbiology and immunology,
O Boehm, and P Markowski, and M van der Giet, and V Gielen, and A Kokalova, and C Brill, and A Hoeft, and G Baumgarten, and R Meyer, and P Knuefermann
Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
July 2008, American journal of physiology. Heart and circulatory physiology,
Copied contents to your clipboard!